Show simple item record

dc.contributor.authorNewton, G
dc.contributor.authorSchneider, M
dc.contributor.otherChapman, K
dc.contributor.otherAqil, R
dc.contributor.otherJarvis, A
dc.coverage.spatialInternational
dc.date.accessioned2020-08-19T09:50:04Z
dc.date.issued2020-06-11
dc.identifierGB2019053429W
dc.identifierWO2020115481
dc.identifier.citation2020
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/3983
dc.description.abstractThis invention relates to compounds that may be useful as inhibitors of Mitogen-activated Protein Kinase Kinase Kinase Kinase-4 (MAP4K4). The invention also relates to the use of these compounds, for example in a method of treatmentof cardiac conditions.In particular, the present invention relates to compounds of formula (I):
dc.languageeng
dc.language.isoeng
dc.subjectKinase
dc.subjectCardiovascular
dc.titleMAP4K4 Inhibitors
dc.typePatent
rioxxterms.licenseref.startdate2020-06-11
rioxxterms.typeOther
pubs.filed-date2018-12-05
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Therapeutics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Therapeutics/Medicinal Chemistry 3
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Therapeutics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Therapeutics/Medicinal Chemistry 3
pubs.patent-statusPCT
pubs.publication-statusPublished
pubs.embargo.termsNot known
icr.researchteamMedicinal Chemistry 3
dc.contributor.icrauthorNewton, Gary


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record